ENST00000699461.1:n.496+3789C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000699461.1(MEG9):​n.496+3789C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0336 in 529,966 control chromosomes in the GnomAD database, including 456 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.031 ( 134 hom., cov: 32)
Exomes 𝑓: 0.035 ( 322 hom. )

Consequence

MEG9
ENST00000699461.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.189

Publications

13 publications found
Variant links:
Genes affected
MEG9 (HGNC:43874): (maternally expressed 9)
MIR412 (HGNC:32064): (microRNA 412) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
MIR369 (HGNC:31783): (microRNA 369) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
MIR409 (HGNC:32055): (microRNA 409) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BA1
GnomAdExome4 highest subpopulation (MID) allele frequency at 95% confidence interval = 0.0519 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIR369NR_029862.1 linkn.-202C>T upstream_gene_variant
MIR412NR_030155.1 linkn.-51C>T upstream_gene_variant
MIR412unassigned_transcript_2446 n.-69C>T upstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MEG9ENST00000699461.1 linkn.496+3789C>T intron_variant Intron 4 of 6
MEG9ENST00000699462.1 linkn.219+1029C>T intron_variant Intron 1 of 3
MEG9ENST00000818609.1 linkn.258+1029C>T intron_variant Intron 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.0308
AC:
4683
AN:
152116
Hom.:
134
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00845
Gnomad AMI
AF:
0.0703
Gnomad AMR
AF:
0.0271
Gnomad ASJ
AF:
0.0880
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0130
Gnomad FIN
AF:
0.0231
Gnomad MID
AF:
0.0411
Gnomad NFE
AF:
0.0463
Gnomad OTH
AF:
0.0373
GnomAD2 exomes
AF:
0.0329
AC:
8254
AN:
251060
AF XY:
0.0335
show subpopulations
Gnomad AFR exome
AF:
0.00938
Gnomad AMR exome
AF:
0.0175
Gnomad ASJ exome
AF:
0.0902
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.0231
Gnomad NFE exome
AF:
0.0475
Gnomad OTH exome
AF:
0.0367
GnomAD4 exome
AF:
0.0347
AC:
13100
AN:
377732
Hom.:
322
Cov.:
0
AF XY:
0.0336
AC XY:
7199
AN XY:
214222
show subpopulations
African (AFR)
AF:
0.0102
AC:
106
AN:
10432
American (AMR)
AF:
0.0170
AC:
617
AN:
36250
Ashkenazi Jewish (ASJ)
AF:
0.0895
AC:
1048
AN:
11706
East Asian (EAS)
AF:
0.00
AC:
0
AN:
12994
South Asian (SAS)
AF:
0.0158
AC:
1054
AN:
66692
European-Finnish (FIN)
AF:
0.0250
AC:
808
AN:
32294
Middle Eastern (MID)
AF:
0.0592
AC:
168
AN:
2836
European-Non Finnish (NFE)
AF:
0.0458
AC:
8607
AN:
187988
Other (OTH)
AF:
0.0418
AC:
692
AN:
16540
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
867
1735
2602
3470
4337
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
42
84
126
168
210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0308
AC:
4685
AN:
152234
Hom.:
134
Cov.:
32
AF XY:
0.0292
AC XY:
2171
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.00842
AC:
350
AN:
41550
American (AMR)
AF:
0.0273
AC:
417
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0880
AC:
305
AN:
3464
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5166
South Asian (SAS)
AF:
0.0131
AC:
63
AN:
4824
European-Finnish (FIN)
AF:
0.0231
AC:
245
AN:
10614
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0463
AC:
3151
AN:
68008
Other (OTH)
AF:
0.0365
AC:
77
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
222
443
665
886
1108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
54
108
162
216
270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0420
Hom.:
225
Bravo
AF:
0.0305
Asia WGS
AF:
0.00491
AC:
18
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
16
DANN
Benign
0.95
PhyloP100
0.19
Mutation Taster
=100/0
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61992670; hg19: chr14-101531733; API